Sandler Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-87,000
Closed -$7.88M 227
2019
Q1
$7.88M Buy
+87,000
New +$7.4M 1.15% 70
2018
Q1
Sell
-65,000
Closed -$5.52M 187
2017
Q4
$5.52M Buy
+65,000
New +$5.45M 1.2% 50
2017
Q3
Sell
-48,800
Closed -$3.77M 184
2017
Q2
$3.77M Sell
48,800
-111,200
-70% -$7.89M 0.59% 88
2017
Q1
$11.1M Buy
+160,000
New +$10.7M 1.16% 34
2016
Q4
Sell
-134,800
Closed -$8.94M 204
2016
Q3
$8.94M Sell
134,800
-70,200
-34% -$4.34M 1.51% 38
2016
Q2
$11.1M Buy
+205,000
New +$11.2M 1.86% 26
2015
Q1
Sell
-130,800
Closed -$8.13M 289
2014
Q4
$8.13M Sell
130,800
-45,351
-26% -$2.59M 0.65% 82
2014
Q3
$9.16M Sell
176,151
-221,049
-56% -$11.3M 0.69% 95
2014
Q2
$20.4M Buy
+397,200
New +$17.9M 1.27% 31

Other funds holding XBI